Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R.
. Mohan A, et al. J Infect Chemother. 2021 Aug 25:S1341-321X(21)00239-7. doi: 10.1016/j.jiac.2021.08.021. Online ahead of print. J Infect Chemother. 2021. PMID: 34483029
.